Evaluation of Costa Rica’s Drug Policy (2005-2025)
This study is part of the COPOLAD III Programme, within Working Group 1.4 on Drug Policy Evaluation, in close collaboration...
This study is part of the COPOLAD III Programme, within Working Group 1.4 on Drug Policy Evaluation, in close collaboration...
On Thursday, 13 November, the Costa Rican Drug Institute (ICD) presented the main findings and recommendations on the evaluation of...
For decades, Ibero-American prison systems have been marked by deep tensions between the punitive function of punishment and the need...
The Cooperation Program on Drugs between the EU and Latin America and the Caribbean (COPOLAD III) held on October 27...
The Cooperation Program on Drugs between the EU and Latin America and the Caribbean (COPOLAD III) held on October 27...
In the framework of the international cooperation programs COPOLAD III and EL PACCTO 2.0, financed by the European Union, official...
On 25 September 2025, the Public Prosecutor’s Office of Paraguay, through the Deputy Prosecutor’s Office of the Specialised Unit against...
When our collaboration with the European Union Drugs Agency (EUDA) wrapped up in March this year, it marked the end...
Mexico City hosted, on 11 and 12 September 2025, the Meeting of National Drug Observatories (OND), an event promoted by...
The European Union's COPOLAD III programme, led by FIAP in consortium with IILA, and in partnership with EUDA and GIZ,...
COPOLAD is a consortium formed by:


Collaborating partners:


© COPOLAD. Programa de Cooperación entre América Latina, el Caribe y la Unión Europea en Políticas sobre Drogas.